Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
sComm is a privately held U.S. assistive technology and medical device company that develops face-to-face communication solutions for deaf, hard of hearing, late-deafened, hearing, and speech-disabled users. The company is best known for the UbiDuo product family, a standalone two-way text communication device designed to enable barrier-free in-person conversations without requiring internet or Wi-Fi. sComm also markets speech generating device configurations of UbiDuo 3 that are positioned for Medicare, Medicaid, private insurance, employer, education, government, and medical settings. The business appears to be commercially focused rather than drug-development oriented, with revenue generated from hardware products and accessibility solutions rather than therapeutics. For a biotech analyst, sComm is best categorized as a healthcare-adjacent assistive/medtech company rather than a biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on sComm.